Quantum-Si (QSI) Liabilities and Shareholders Equity (2020 - 2026)
Quantum-Si's (QSI) quarterly Liabilities and Shareholders Equity came in at $213.3 million in Q1 2026, down 21.34% year-on-year from $271.2 million in Q1 2025, and down 13.13% on a QoQ basis from $245.6 million in Q4 2025.
Quantum-Si (QSI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Quantum-Si (QSI) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $213.3 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 21.34% year-over-year to $213.3 million in Q1 2026; TTM through Mar 2026 was $973.5 million, a 3.83% decrease from a year earlier, with the FY2025 full-year figure at $245.6 million, down 0.91% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $213.3 million, down from $245.6 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for QSI reached as high as $476.1 million in Q1 2022 and fell as low as $213.3 million in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $312.5 million across 5 years, with a median of $275.6 million in 2024.
- Across the five-year window, Liabilities and Shareholders Equity soared 311.32% in 2022 and retreated 25.67% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $391.5 million in 2022, then retreated by 23.82% to $298.2 million in 2023, then slipped by 16.89% to $247.9 million in 2024, then slipped by 0.91% to $245.6 million in 2025, then retreated by 13.13% to $213.3 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $213.3 million in Q1 2026, $245.6 million in Q4 2025, and $260.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Quantum-Si | 171.01 Mn | 43.67 Mn | 74,000.00 | 213.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213.35 Mn |
| Dec 31, 2025 | 245.61 Mn |
| Sep 30, 2025 | 260.13 Mn |
| Jun 30, 2025 | 254.41 Mn |
| Mar 31, 2025 | 271.22 Mn |
| Dec 31, 2024 | 247.87 Mn |
| Sep 30, 2024 | 236.45 Mn |
| Jun 30, 2024 | 256.75 Mn |
| Mar 31, 2024 | 275.59 Mn |
| Dec 31, 2023 | 298.25 Mn |
| Sep 30, 2023 | 318.10 Mn |
| Jun 30, 2023 | 341.17 Mn |
| Mar 31, 2023 | 365.03 Mn |
| Dec 31, 2022 | 391.49 Mn |
| Sep 30, 2022 | 417.98 Mn |
| Jun 30, 2022 | 443.25 Mn |
| Mar 31, 2022 | 476.14 Mn |
| Dec 31, 2021 | 503.23 Mn |
| Sep 30, 2021 | 509.53 Mn |
| Jun 30, 2021 | 526.95 Mn |